Total Payments
$447,823
2023 Payments
$18,292
Companies
7
Transactions
163
Payment Breakdown by Category
Consulting$427,560 (95.5%)
Travel$17,792 (4.0%)
Food & Beverage$2,471 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $427,560 | 115 | 95.5% |
| Travel and Lodging | $17,792 | 18 | 4.0% |
| Food and Beverage | $2,471 | 30 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $357,514 | 131 | $0 (2023) |
| Relypsa, Inc. | $38,140 | 18 | $0 (2020) |
| Vifor Fresenius Medical Care Renal Pharma Ltd. | $18,054 | 3 | $0 (2021) |
| Alnylam Pharmaceuticals Inc. | $13,683 | 3 | $0 (2023) |
| Vifor Pharma, Inc. | $11,108 | 4 | $0 (2023) |
| Vifor (International) Ltd. | $9,186 | 2 | $0 (2021) |
| Medtronic USA, Inc. | $138.44 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $18,292 | 5 | Bayer Healthcare Pharmaceuticals Inc. ($8,731) |
| 2022 | $73,339 | 18 | Bayer HealthCare Pharmaceuticals Inc. ($62,152) |
| 2021 | $101,771 | 34 | Bayer HealthCare Pharmaceuticals Inc. ($81,513) |
| 2020 | $99,449 | 36 | Bayer HealthCare Pharmaceuticals Inc. ($65,099) |
| 2019 | $77,060 | 39 | Bayer HealthCare Pharmaceuticals Inc. ($73,113) |
| 2018 | $37,737 | 18 | Bayer HealthCare Pharmaceuticals Inc. ($33,999) |
| 2017 | $40,174 | 13 | Bayer HealthCare Pharmaceuticals Inc. ($32,906) |
All Payment Transactions
163 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/18/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Consulting Fee | Cash or cash equivalent | $2,443.75 | General |
| Category: Cardio-renal | ||||||
| 04/18/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Consulting Fee | Cash or cash equivalent | $2,012.50 | General |
| Category: Cardio-renal | ||||||
| 03/07/2023 | Vifor Pharma, Inc. | Korsuva (Drug) | Consulting Fee | Cash or cash equivalent | $5,445.00 | General |
| Category: CKD-aP | ||||||
| 02/20/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Consulting Fee | Cash or cash equivalent | $4,275.00 | General |
| Category: Cardio-renal | ||||||
| 02/02/2023 | Alnylam Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $4,116.00 | General |
| 12/22/2022 | Bayer HealthCare Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $6,998.75 | General |
| 11/04/2022 | Bayer HealthCare Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $7,376.00 | General |
| 11/04/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Consulting Fee | Cash or cash equivalent | $4,835.00 | General |
| Category: Cardio-renal | ||||||
| 08/17/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Consulting Fee | Cash or cash equivalent | $8,014.00 | General |
| Category: Cardio-renal | ||||||
| 08/10/2022 | Bayer HealthCare Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $6,615.00 | General |
| 07/19/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Consulting Fee | Cash or cash equivalent | $5,344.00 | General |
| Category: Cardio-renal | ||||||
| 06/16/2022 | Alnylam Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $5,562.00 | General |
| 06/09/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $101.60 | General |
| Category: Cardio-renal | ||||||
| 05/04/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Consulting Fee | Cash or cash equivalent | $1,425.00 | General |
| Category: Cardio-renal | ||||||
| 04/28/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Consulting Fee | Cash or cash equivalent | $4,512.50 | General |
| Category: Cardio-renal | ||||||
| 04/28/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| Category: Cardio-renal | ||||||
| 04/14/2022 | Bayer HealthCare Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $4,581.00 | General |
| 04/14/2022 | Bayer HealthCare Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $1,780.00 | General |
| 03/10/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Consulting Fee | Cash or cash equivalent | $8,143.00 | General |
| Category: Cardio-renal | ||||||
| 03/10/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Consulting Fee | Cash or cash equivalent | $1,425.00 | General |
| Category: Cardio-renal | ||||||
| 03/10/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $51.34 | General |
| Category: Cardio-renal | ||||||
| 01/18/2022 | Vifor Pharma, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,525.00 | General |
| 01/18/2022 | Vifor Pharma, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| 12/22/2021 | Alnylam Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $4,005.00 | General |
| 12/11/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Consulting Fee | Cash or cash equivalent | $6,650.00 | General |
| Category: Cardio-renal | ||||||
About Dr. Murray Epstein, MD
Dr. Murray Epstein, MD is a Nephrology healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225067713.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Murray Epstein, MD has received a total of $447,823 in payments from pharmaceutical and medical device companies, with $18,292 received in 2023. These payments were reported across 163 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($427,560).
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Hospitalist
- Location Miami, FL
- Active Since 06/30/2006
- Last Updated 09/11/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1225067713
Products in Payments
- Non-Covered $190,343
- Non-Covered (Drug) $73,113
- Kerendia (Drug) $66,707
- Veltassa (Drug) $65,268
- Korsuva (Drug) $5,445
- KYPHON Balloon Kyphoplasty (Device) $138.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Miami
Gabriel Contreras, Md, Mph, MD, MPH
Nephrology — Payments: $207,450
Nephrology $207,450
Alessia Fornoni, Md, Phd, MD, PHD
Nephrology — Payments: $80,140
Nephrology $80,140
David Roth, Md, MD
Nephrology — Payments: $59,747
Nephrology $59,747
Dr. Jonathan Da Costa, M.d, M.D
Nephrology — Payments: $45,108
Nephrology $45,108
Jorge Busse, Md, MD
Nephrology — Payments: $42,367
Nephrology $42,367
Loay Salman, Md, MD
Nephrology — Payments: $41,036
Nephrology $41,036